logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Robert J Szendroi

This inventor holds 7 USPTO granted patents. Top assignees: Agouron Pharmaceuticals, Inc., Japan Tobacco Inc., Other. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert J Szendroi. Retrieved from https://idiyas.com/inventor/robert-j-szendroi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 71.4

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal5 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
silverMedal2 out of 1,067 
 
Japan Tobacco Inc.
 patents
bronzeMedal2 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2002

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6465661 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-10-15),
2. 6392067 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-05-21),
3. 6316625 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2001-11-13),
4. 6117999 - Methods of making HIV-protease inhibitors and intermediates for making (2000-09-12),
5. 6084107 - Intermediates for making HIV-protease inhibitors (2000-07-04),
6. 5925759 - Methods of making HIV-protease inhibitors and intermediates for making (1999-07-20),
7. 5705647 - Intermediates for making HIV-protease inhibitors (1998-01-06),

Title: Innovator Spotlight: Robert J Szendroi

Introduction

Robert J Szendroi is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmaceutical inventions. With a remarkable portfolio of seven patents, Szendroi has focused his research on the development of HIV-protease inhibitors, which play a crucial role in combating the HIV virus.

Latest Patents

Among his latest patents are innovative methods for making HIV-protease inhibitors and their intermediates. These inhibitors work by blocking the biological activity of the HIV protease enzyme, thereby halting the replication process of the HIV virus. The compounds developed by Szendroi can be synthesized using novel methods and intermediates, enhancing the efficacy of treatments available for HIV.

Career Highlights

Throughout his career, Robert J Szendroi has collaborated with renowned companies in the pharmaceutical industry. He has notably worked with Agouron Pharmaceuticals, Inc. and Japan Tobacco Inc., where he contributed to the advancement of medicinal chemistry and drug development.

Collaborations

In addition to his work at various companies, Szendroi has joined forces with esteemed colleagues such as Srinivasan Babu and Bennett C Borer. Their collaboration has fostered a creative environment conducive to innovation in pharmaceutical research and development.

Conclusion

Robert J Szendroi's dedication to inventing effective therapeutic solutions highlights his significant role in the fight against HIV. His innovative methods and collaborative spirit continue to inspire advancements in the medical field, making a positive impact on global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…